Naproxen in osteoarthrosis. Double-blind crossover trial.

In this double-blind crossover trial, naproxen (750 mg/day) was compared to placebo for the treatment of osteoarthrosis of the hip and knee. Patients were randomly assigned to treatment with either naproxen or placebo for 4 weeks and then to treatment with the alternate agent for a second 4-week per...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Blechman, W, Willkens, R, Boncaldo, G L, Hoffmeister, R T, Lockie, L M, Multz, C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1978
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1000197/
https://ncbi.nlm.nih.gov/pubmed/343726
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak